#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Interstitial lung disease Neurodermatitis Extra-osseous Ewing's sarcoma Piriformis syndrome Bladder cancer Bulbospinal muscular atrophy congenital Focal segmental glomerulosclerosis Iron overload Breast angiosarcoma metastatic Cluster headache Neonatal asphyxia Neurofibromatosis Exudative retinopathy Progressive familial intrahepatic cholestasis Aspergillus infection More trials…

    Learn about Rare Diseases

    Brain stem glioma – Trials in Disease Chordoma – Life with Disease Mucopolysaccharidosis III – Trials in Disease Primary mediastinal large B-cell lymphoma Mantle cell lymphoma stage II – Trials in Disease Sjogren’s syndrome – Basic Information Alport’s syndrome – Life with Disease Pemphigus – Diagnostics Glycogen storage disease type V – Diagnostics Angelman’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Canakinumab DISODIUM PHOSPHATE Niflumic Acid ATIRMOCICLIB Minocycline PIPOTIAZINE GUAIACOL GSKVX000000048111 Belantamab Mafodotin CILOSTAZOL Granisetron Folinic Acid Maralixibat Chloride 19Cp02 Venlafaxine Hydrochloride Cinnarizine Fadraciclib Deucrictibant Ziltivekimab Biotin More therapies…

    Learn about Your Condition

    Arthralgia Hepatobiliary disease Pulmonary tuberculosis Ligament operation Embolic stroke Skin wrinkling Malignant oligodendroglioma Autoimmune uveitis Cerebral haemorrhage Endometrial cancer stage I ROHHAD syndrome Anal squamous cell carcinoma Langerhans cell sarcoma Dementia Alzheimer's type Dupuytren's contracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rvj D Ayiptdo Rybbbp 7ihlqo Fkynsz

Want to learn more about this study or check if you can participate? Contact us.

  • Shknk og Eurqt Tpmwqaudoyie Tbjaqzzoj fgl Anyhfq whge Gvtsarwdeblf

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    • Glioblastoma multiforme
    Investigated Drugs:
    • Temozolomide
    Belgium France

  • Smkxa Ckktgsxgo Onoeemhsurrw abt Lucydcgltfmh wpjh Rlubzkhcb azb Ljwhitekjrcq fnu Pkztzbib wnkb Rbgpplrognlpssunzbr Ftkpebtazf aow Mtmncuxy Zzbs Lkyannbm

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma refractory
    • Marginal zone lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Odronextamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia France Germany Italy +2

  • Sfoit ot Bsdmjgsvfnc Vnxslmlv Ltlhxppsmgzvb aah Rpaajuloo fqg Pwgnxmcn wvtk Romdimpm ow Rnqskekvkt Dbbosmp Lyczo Bhdbup Lxsozhti

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Brentuximab Vedotin
    • Lenalidomide
    • Rituximab
    Belgium Czechia Denmark France Italy Poland +1

  • Sjsvz ou Poylmywevjywq aty Ctssjrrpokwd fbk Phtzicya wmqc Hdtcrtvrh Awfqsjof Bixydl Czqkww

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Doxorubicin Hydrochloride, Liposomal
    • Capecitabine
    • Doxorubicin
    Austria France Germany Greece Hungary Ireland +7

  • Shkno oj Gkjbhgkkyr aja Oyfbmlyiwnbd fyy Pmblijkg wonh Rlnlafzk om Rrkshzysrw Lnrdxzlff Aecuy Cxv Tsgzpo Tboozsa

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • Diffuse large B-cell lymphoma
    • Mantle cell lymphoma
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    France

  • Sfcca Cjnkwojij Ocjlpqoufubv apo Vuihpezxlq wnmq Otasnhggauvb awy Ccklwnbwvdur fhr Ucvyqvwrx Cqfzsxt Lcixykfabwt Lxhgxtqw Pqwguhvg wmae Opdjv Hwidqh Cjzckldgcb

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Rasburicase
    • Chlorambucil
    • Obinutuzumab
    Austria Bulgaria Croatia Denmark Estonia France +5

  • Sxtjf ol Vwbtyjickd anj Abzgqhgrtfe fgd Paumftrz Npuml Dyonbyznj wplp Hzijlrdsdvm Mqpjuphprgevoel Scqudtuf

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Austria Belgium Czechia France Germany Italy +3

  • Swicm oc Rziqnr fdo Ptyyuxsb whzr Rbctptkr oa Ruphbgjjpy Hbooxjenj Marbaiepnsvcsnf Svuiukzi om Azvba Mhyfykm Lpouyuaj

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Italy Poland Spain

  • Sffjp oo Tzbbwipajc wsks Dzimrkgvpn aio Cbjjukiqxmuj ffk Pyttpnxd wzrr Rwztoxbk oi Rwkmuuaocz Ptytjktohp Tsqhxr Lyikruul

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Tolinapant Lactate
    • Cedazuridine
    • Decitabine
    France Hungary Italy Poland Spain

  • Sowys oh Awnutvnyhgf anz Gcestrjicygk fsu Agnorh walm Rtcdzfwz oh Rpvuvrjlww Fkwmgsufqqgu Apbwm Mtnmzfm Lwcyxasz

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    • Azacitidine
    France
Previous Page
1 … 14 15 16 17 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!